ChemicalBook > Articles Catagory List >API >an-injectable-anabolic-steroid-drostanolone

An injectable anabolic steroid---Drostanolone

Jan 24，2022

Drostanolone is an injectable anabolic steroid, a derivative of dihydrotestosterone (DHT). It is described in medical literature as a strong anabolic with anti-estrogenic traits. The FDA approved drostanolone for the treatment of inoperable breast cancer in climacteric women, as was the case in many other parts of the worlds.

Article illustration

Function

Drostanolone Enanthate is well known as one of the best anabolic steroids. This is because of how it is able to prevent estrogenic properties from developing. Since it won’t increase levels of estrogen, it can be useful without causing negative side effects in this regard. It is also this function of Drostanolone Enanthate that made it so successful to fight breast cancer in those early years of medical use.

Bodybuilders realize they must control estrogen levels, and it can be tough to do so with some of the anabolic steroids out there. Lower estrogen means a better result and it also means more definition during the cutting cycle. Another function of Drostanolone Enanthate is being able to reduce body fat.

Characteristics

Drostanolone Enanthate is a Dihydrotestosterone (DHT) based anabolic steroid. However, the DHT has been altered in terms of the hormone structure. The change is the result of a methyl group added. This prevents the hormone from breaking down metabolically. It also increases the anabolic nature of Drostanolone Enanthate. This is when the ester is attached. Keep in mind, Enanthate isn’t actually a steroid component. It is a tool used to offer the right timing for the product.

Biological Activity

Metabolite detection times were recorded and S4 (2α-methyl-5α-androstan-17-one-6β-ol-3α-sulfate) and G1 (2α-methyl-5α-androstan-17-one-3α-glucuronide) were thought to be new potential biomarkers for drostanolone misuse which can be detected up to 24days by liquid-liquid extraction and 7days by direct-injection analysis after intramuscular injection. S4 and G1 were also detected in two drostanolone-positive routine urine samples.